BlackRock Amends Gilead Sciences Stake (13G/A)
Ticker: GILD · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 882095
| Field | Detail |
|---|---|
| Company | Gilead Sciences, INC. (GILD) |
| Form Type | SC 13G/A |
| Filed Date | Jan 24, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its passive stake in Gilead Sciences as of year-end 2023.**
AI Summary
BlackRock Inc. filed an amended Schedule 13G/A on January 24, 2024, indicating its ownership of Gilead Sciences Inc. common stock as of December 31, 2023. This filing, Amendment No. 15, updates BlackRock's passive investment stake in Gilead. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal its confidence (or lack thereof) in Gilead's future performance, potentially influencing other investors.
Why It Matters
This filing shows BlackRock's updated passive ownership in Gilead Sciences, providing transparency on a significant institutional investor's position.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should note BlackRock's continued passive stake in Gilead Sciences, but this routine update doesn't suggest any immediate buy or sell action. It's a data point for understanding institutional ownership.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Gilead Sciences Inc. (company) — the issuer whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 24, 2024 (date) — the filing date of the SC 13G/A
- Amendment No: 15 (number) — the specific amendment number of this filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 15)' sections.
Who is the 'reporting person' in this filing?
The reporting person, or the entity making the filing, is BlackRock Inc., as indicated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
Which company's securities are being reported on?
The securities being reported on belong to GILEAD SCIENCES, INC., as stated under the 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES, INC.' section and 'GILEAD SCIENCES INC (Name of Issuer)'.
What was the 'Date of Event Which Requires Filing of this Statement'?
The date of the event which required this filing was December 31, 2023, as explicitly stated in the filing under 'December 31, 2023 (Date of Event Which Requires Filing of this Statement)'.
What is the CUSIP number for the securities mentioned?
The CUSIP number for the Common Stock of Gilead Sciences Inc. is 375558103, as listed under '(CUSIP Number) 375558103'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding GILEAD SCIENCES, INC. (GILD).